MedPath

Risk of Post-polypectomy Bleeding With Prophylactic Hemoclipping

Not Applicable
Completed
Conditions
Elective Colonoscopy
Post-polypectomy Bleeding
Polypectomy
Registration Number
NCT01647581
Lead Sponsor
VA Office of Research and Development
Brief Summary

A randomized trial aimed at determining whether or not hemoclips are effective in preventing post-polypectomy bleeds on polyps that are 10mm in size or greater.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
11182
Inclusion Criteria
  • Patients presenting for elective colonoscopy
Exclusion Criteria
  • Patients in which polypectomy can not be performed safely

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Number of Patients With Delayed Post Polypectomy Bleeding30 days

rectal bleeding with associated Hb 2g drop, hemodynamic instability, or need for repeat colonoscopy or angiography or surgery

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX

🇺🇸

Dallas, Texas, United States

South Texas Health Care System, San Antonio, TX

🇺🇸

San Antonio, Texas, United States

Central Texas Veterans Health Care System, Temple, TX

🇺🇸

Temple, Texas, United States

VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
🇺🇸Dallas, Texas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.